Page last updated: 2024-08-18

pyrroles and ta-8995

pyrroles has been researched along with ta-8995 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barter, PJ; Brewer, HB; Ford, J; Hovingh, GK; Kastelein, JJ; Rader, DJ; Round, P; Saleheen, D; van Deventer, SJ1

Trials

1 trial(s) available for pyrroles and ta-8995

ArticleYear
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial.
    Lancet (London, England), 2015, Aug-01, Volume: 386, Issue:9992

    Topics: Adolescent; Adult; Aged; Atorvastatin; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Denmark; Double-Blind Method; Dyslipidemias; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Netherlands; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Young Adult

2015